CURE Pharmaceutical to Present at the 9th Annual LD Micro Invitational
May 30, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, May 30, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 9th Annual LD...
CURE Pharmaceutical Extends Closing Of Privately-Held Chemistry Holdings Inc. Acquisition to May 13
May 01, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has extended the close of the...
Cure Pharmaceutical [OTCQB:CURR] to Present at the “Planet MicroCap Showcase 2019”
April 30, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
LAS VEGAS, April 30, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the Planet MicroCap...
CURE Pharmaceutical To Present at Benzinga Cannabis Capital Conference
January 09, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, Jan. 09, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will host an investor presentation at the...
Prominent Biotech Investor Gene Salkind Adds Another $2M Investment in CURE Pharmaceutical
November 01, 2018 07:25 ET
|
CURE Pharmaceutical
OXNARD, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, has announced that the company secured a $2 million investment...
CURE Pharmaceutical to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex House
September 28, 2018 07:25 ET
|
CURE Pharmaceutical
NEW YORK, Sept. 28, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, will be presenting at this year's MicroCap Conference on October...
Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Ltd.
July 11, 2018 08:57 ET
|
CURE Pharmaceutical
OXNARD, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, announced today that it has signed a term sheet...